Melanoma classification and management in the era of molecular medicine
Dermatologic Clinics · 2023-01 · 41 (1) · 49-63
DOI: 10.1016/j.det.2022.07.017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Dermatologic Clinics, 2023-01. Verfasst von Sarem Rashid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Boston University School of Medicine…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 115 Literaturangaben.
Abstract (Originalsprache)
Melanoma is the most lethal form of skin cancer although surgery is often curative when combined with early screening and prevention. In recurrent or advanced cancer, the emergence of chemotherapy, targeted therapy, and immune checkpoint inhibitors has demonstrated promising clinical outcomes. Such approaches can remarkably halt the progression of disease for many years, although are limited by the acquisition of resistance. The development and approval of combination therapies has further changed the treatment paradigm for certain melanomas. This review focuses on the current state of melanoma epidemiology and recent advancements in melanoma screening, histopathological classification, staged excision (i.e. wide local excision, sentinel lymph node biopsy, and Mohs micrographic surgery), and systemic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Boston University School of Medicine, Boston, MA 02118, USA.
- Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA.
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: htsa…
Zitieren
APA
Rashid, S., Shaughnessy, M., & Tsao, H. (2023). Melanoma classification and management in the era of molecular medicine. Dermatologic Clinics, 41(1), 49-63. https://doi.org/10.1016/j.det.2022.07.017
Vancouver
Rashid S, Shaughnessy M, Tsao H. Melanoma classification and management in the era of molecular medicine. Dermatologic Clinics. 2023;41(1):49-63. doi:10.1016/j.det.2022.07.017
BibTeX
@article{Rashid2023,
author = {Rashid, Sarem and Shaughnessy, Michael and Tsao, Hensin},
title = {Melanoma classification and management in the era of molecular medicine},
journal = {Dermatologic Clinics},
year = {2023},
volume = {41},
number = {1},
pages = {49--63},
doi = {10.1016/j.det.2022.07.017}
}
EUVIMED